Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-17-002507
Filing Date
2017-11-22
Accepted
2017-11-22 16:59:03
Documents
53

Document Format Files

Seq Description Document Type Size
1 FORM S-1 nemus_s1.htm S-1 1486537
2 OPINION RE: LEGALITY nemus_ex51.htm EX-5.1 12660
3 CONSENT OF MAYER HOFFMAN MCCANN P.C. nemus_ex231.htm EX-23.1 1406
10 nemus_s1img1.jpg GRAPHIC 11220
11 nemus_s1img2.jpg GRAPHIC 7331
  Complete submission text file 0001640334-17-002507.txt   6380613

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nmus-20170930.xml EX-101.INS 1178329
5 XBRL TAXONOMY EXTENSION SCHEMA nmus-20170930.xsd EX-101.SCH 53840
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nmus-20170930_cal.xml EX-101.CAL 36491
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nmus-20170930_def.xml EX-101.DEF 267231
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nmus-20170930_lab.xml EX-101.LAB 449524
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nmus-20170930_pre.xml EX-101.PRE 331999
Mailing Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626
Business Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-221733 | Film No.: 171220501
SIC: 2834 Pharmaceutical Preparations